Why do I have clay-colored stools?

Clay-colored or pale stools typically indicate a lack of bile reaching your intestines, often due to liver, gallbladder, or bile duct issues. While occasional pale stools may be diet-related, persistent changes warrant medical evaluation and testing of liver function biomarkers.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

What Are Clay-Colored Stools?

Clay-colored stools, also called acholic stools, are bowel movements that appear pale, gray, white, or putty-colored instead of the normal brown color. This unusual coloration occurs when stool lacks bile pigments, which normally give feces their characteristic brown hue. The medical term for this condition is acholia, meaning absence of bile.

Normal stool gets its brown color from bilirubin, a waste product created when your body breaks down old red blood cells. Your liver processes bilirubin and releases it into bile, which flows through your digestive system. When this process is disrupted, stools can lose their normal coloration and appear clay-like or pale.

Normal vs. Abnormal Stool Colors

Understanding what constitutes normal versus abnormal stool color can help you recognize when something might be wrong. Normal stool colors range from light to dark brown, with variations based on diet and hydration. Clay-colored stools stand out as distinctly different, appearing pale gray, white, yellow-gray, or resembling putty or clay.

Stool Color Guide and Clinical Significance

Stool color changes should be evaluated in context with other symptoms and duration.
Stool ColorAppearancePossible CausesMedical Urgency
Normal BrownBrown (light to dark)Well-formed, smoothNormal bile pigmentationNone
Clay/PaleGray, putty, or pale tanMay be loose or formedBile duct obstruction, liver diseaseModerate to High
WhiteCompletely whiteOften greasyComplete bile obstructionHigh - Seek immediate care
YellowBright yellowOften looseMalabsorption, celiac diseaseModerate

Stool color changes should be evaluated in context with other symptoms and duration.

Common Causes of Clay-Colored Stools

Several conditions can interrupt the normal flow of bile into your intestines, resulting in pale or clay-colored stools. These causes range from temporary blockages to chronic liver conditions, each requiring different approaches to diagnosis and treatment.

Bile Duct Obstruction

Bile duct obstruction is one of the most common causes of clay-colored stools. This can occur due to gallstones blocking the common bile duct, tumors in the bile duct or pancreas, strictures (narrowing) of the bile ducts, or inflammation of the bile ducts (cholangitis). When bile cannot reach the intestines, stools lose their brown color and appear pale or clay-like.

Liver Conditions

Various liver diseases can impair bile production or flow, leading to clay-colored stools. These include:

  • Hepatitis (viral, alcoholic, or autoimmune)
  • Cirrhosis (scarring of the liver)
  • Fatty liver disease
  • Primary biliary cholangitis
  • Primary sclerosing cholangitis
  • Liver cancer or metastases

These conditions affect the liver's ability to produce bile or transport it effectively, resulting in pale stools along with other symptoms like jaundice, fatigue, and abdominal pain.

Medications and Supplements

Certain medications can cause clay-colored stools as a side effect. Common culprits include antacids containing aluminum hydroxide, barium used in medical imaging tests, certain antibiotics like rifampin, and some anti-diarrheal medications. If you notice pale stools after starting a new medication, consult your healthcare provider about potential alternatives.

Associated Symptoms to Watch For

Clay-colored stools rarely occur in isolation. Understanding the accompanying symptoms can help identify the underlying cause and determine the urgency of medical evaluation. Pay attention to these warning signs that often accompany pale stools:

  • Jaundice (yellowing of skin and eyes)
  • Dark urine (tea or cola-colored)
  • Abdominal pain, especially in the upper right quadrant
  • Nausea and vomiting
  • Fever and chills
  • Unexplained weight loss
  • Chronic fatigue
  • Itchy skin (pruritus)
  • Loss of appetite

The combination of symptoms can provide important clues about the underlying condition. For example, clay-colored stools with jaundice and dark urine strongly suggest bile duct obstruction or liver disease.

Diagnostic Tests and Biomarkers

If you're experiencing persistent clay-colored stools, your healthcare provider will likely order several tests to identify the underlying cause. Blood tests are typically the first step in evaluation, focusing on liver function and bile flow markers.

Key Liver Function Tests

Essential biomarkers for evaluating liver health and bile flow include:

  • Bilirubin (total and direct) - Elevated levels indicate impaired bile flow
  • ALT and AST - Liver enzymes that rise with liver cell damage
  • Alkaline phosphatase (ALP) - Increases with bile duct obstruction
  • Albumin - Decreases with chronic liver disease
  • Total protein - May be abnormal in liver disease

Regular monitoring of these biomarkers can help track liver health and identify problems early. If you're concerned about your liver function or digestive health, comprehensive testing can provide valuable insights into your metabolic and liver health status.

Imaging Studies

Beyond blood tests, imaging studies help visualize the liver, gallbladder, and bile ducts. Common imaging tests include abdominal ultrasound to detect gallstones or bile duct dilation, CT scan for detailed liver and pancreas imaging, MRCP (magnetic resonance cholangiopancreatography) for bile duct visualization, and ERCP (endoscopic retrograde cholangiopancreatography) for both diagnosis and treatment of bile duct problems.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

When to Seek Medical Attention

While a single episode of pale stool might not be cause for alarm, certain situations require prompt medical evaluation. Seek immediate medical attention if you experience:

  • Persistent clay-colored stools lasting more than 2-3 days
  • Jaundice or yellowing of the skin and eyes
  • Severe abdominal pain
  • High fever with chills
  • Persistent vomiting
  • Signs of dehydration
  • Confusion or altered mental state

These symptoms may indicate serious conditions like acute cholangitis, severe hepatitis, or complete bile duct obstruction that require urgent treatment.

Treatment Options and Management

Treatment for clay-colored stools depends entirely on the underlying cause. Once your healthcare provider identifies the root problem through testing and imaging, they can develop an appropriate treatment plan.

Medical Interventions

For bile duct obstructions caused by gallstones, treatment may involve ERCP with stone removal or surgery (cholecystectomy) to remove the gallbladder. Strictures or tumors might require stent placement to open blocked ducts or surgical resection. Liver conditions are treated based on their specific cause, such as antiviral medications for hepatitis or lifestyle modifications for fatty liver disease.

Lifestyle Modifications

Supporting liver health through lifestyle changes can help manage and prevent conditions that cause clay-colored stools:

  • Limit alcohol consumption or abstain completely
  • Maintain a healthy weight through balanced nutrition
  • Exercise regularly to support metabolic health
  • Avoid hepatotoxic substances and unnecessary medications
  • Stay hydrated to support bile flow
  • Eat a diet rich in fruits, vegetables, and whole grains

For those interested in monitoring their liver health proactively, you can upload your existing blood test results for a comprehensive analysis at SiPhox Health's free upload service. This service provides personalized insights and actionable recommendations based on your biomarker data, helping you track your liver function over time.

Prevention and Long-term Monitoring

Preventing clay-colored stools involves maintaining optimal liver and digestive health. Regular monitoring of liver function biomarkers can help detect problems before symptoms develop, allowing for early intervention and better outcomes.

Key prevention strategies include maintaining a healthy weight to prevent fatty liver disease, limiting alcohol intake to protect liver cells, getting vaccinated against hepatitis A and B, practicing safe behaviors to avoid hepatitis C, and managing chronic conditions like diabetes that affect liver health. Regular health screenings, including comprehensive metabolic panels that assess liver function, can identify issues early when they're most treatable.

The Bottom Line on Clay-Colored Stools

Clay-colored stools are an important warning sign that shouldn't be ignored. While occasional pale stools might result from dietary factors or medications, persistent changes in stool color often indicate problems with bile production or flow. The key is recognizing when this symptom requires medical attention and understanding what tests and treatments might be necessary.

If you notice clay-colored stools, especially with other symptoms like jaundice, abdominal pain, or dark urine, consult your healthcare provider promptly. Early diagnosis and treatment of underlying liver or bile duct conditions can prevent serious complications and improve long-term health outcomes. Regular monitoring of liver function biomarkers, maintaining a healthy lifestyle, and staying informed about your digestive health are essential steps in preventing and managing conditions that cause clay-colored stools.

References

  1. Roche SP, Kobos R. Jaundice in the adult patient. American Family Physician. 2004;69(2):299-304.[Link][PubMed]
  2. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of cholestatic liver diseases. Journal of Hepatology. 2009;51(2):237-267.[Link][DOI]
  3. Fargo MV, Grogan SP, Saguil A. Evaluation of Jaundice in Adults. American Family Physician. 2017;95(3):164-174.[Link][PubMed]
  4. Modha K. Clinical Approach to Patients With Obstructive Jaundice. Techniques in Vascular and Interventional Radiology. 2015;18(4):197-200.[PubMed][DOI]
  5. Beckingham IJ, Ryder SD. ABC of diseases of liver, pancreas, and biliary system: Investigation of liver and biliary disease. BMJ. 2001;322(7277):33-36.[Link][PubMed][DOI]
  6. Vítek L, Ostrow JD. Bilirubin chemistry and metabolism; harmful and protective aspects. Current Pharmaceutical Design. 2009;15(25):2869-2883.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my liver function biomarkers at home?

You can test your liver function biomarkers at home with SiPhox Health's Heart & Metabolic Program, which includes comprehensive liver function testing including ALT, AST, bilirubin, alkaline phosphatase, and total protein, providing lab-quality results from the comfort of your home.

What is the difference between clay-colored and white stools?

Clay-colored stools appear pale gray, putty-colored, or light tan, while white stools are completely devoid of color. Both indicate absence of bile pigments, but white stools often suggest complete bile duct obstruction and require immediate medical attention.

Can stress cause clay-colored stools?

While stress alone doesn't directly cause clay-colored stools, chronic stress can affect liver function and digestive health over time. Stress may worsen existing liver conditions or contribute to digestive issues that indirectly affect stool color.

How long should I wait before seeing a doctor for pale stools?

If clay-colored stools persist for more than 2-3 days or are accompanied by jaundice, abdominal pain, or dark urine, see a doctor immediately. A single episode after eating certain foods or taking antacids may not require urgent care but should be monitored.

Are clay-colored stools always a sign of serious illness?

Not always. Temporary causes like certain medications, antacids, or barium from medical tests can cause pale stools. However, persistent clay-colored stools often indicate liver, gallbladder, or bile duct problems that require medical evaluation.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details